Patents by Inventor Kevin D. Laugero

Kevin D. Laugero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
    Publication number: 20130184213
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Application
    Filed: February 26, 2013
    Publication date: July 18, 2013
    Applicants: Astrazeneca Pharmaceuticals LP, Amylin Pharmaceuticals, LLC
    Inventors: Kevin D. LAUGERO, Michael R. Hanley, Christine M. Mack, David G. Parkes, Andrew A. Young
  • Amylin and amylin agonists for treating psychiatric diseases and disorders
    Patent number: 8389477
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: March 5, 2013
    Assignees: Amylin Pharmaceuticals, LLC, AstraZeneca Pharmaceuticals LP
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Andrew A. Young
  • Neuromedin and FN-38 Peptides for Psychotic Diseases
    Publication number: 20130035294
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Application
    Filed: October 12, 2012
    Publication date: February 7, 2013
    Applicant: Amylin Pharmaceuticals, LLC
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Paul McGonigle
  • Neuromedin and FN-38 peptides for treating psychiatric diseases
    Patent number: 8309522
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: November 13, 2012
    Assignee: Amylin Pharmaceuticals, LLC
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Paul McGonigle
  • Method of modifying food preference comprising administering amylin or amylin agonist
    Patent number: 8278267
    Abstract: Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: October 2, 2012
    Assignee: Amylin Pharmaceuticals, LLC
    Inventors: Christian Weyer, Kevin D. Laugero, Christine M. Mack, David G. Parkes
  • AMYLIN AND AMYLIN AGONISTS FOR TREATING PSYCHIATRIC DISEASES AND DISORDERS
    Publication number: 20110288028
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Application
    Filed: May 20, 2011
    Publication date: November 24, 2011
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Andrew A. Young
  • COMPOSITIONS AND METHODS FOR THE CONTROL, PREVENTION AND TREATMENT OF OBESITY AND EATING DISORDERS
    Publication number: 20110263491
    Abstract: Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet and nutrition are provided. The methods provided generally involve the administration of an Amylin or an Amylin agonist to a subject in order to prevent, treat or control conditions or disorders associated with obesity, diet and nutrition.
    Type: Application
    Filed: December 9, 2010
    Publication date: October 27, 2011
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Christian WEYER, Kevin D. Laugero, Christine M. Mack, David G. Parkes
  • Methods for controlling binge eating disorders
    Patent number: 7879794
    Abstract: Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet, and nutrition are provided. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to prevent, treat or controlling conditions or disorders associated with obesity, diet, and nutrition.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: February 1, 2011
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Christian Weyer, Kevin D. Laugero, Christine M. Mack, David G. Parkes
  • Neuromedin and FN-38 Peptides for Treating Psychiatric Diseases
    Publication number: 20100168013
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Application
    Filed: February 4, 2008
    Publication date: July 1, 2010
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Kevin D. Laugero, Michael R. Hanley, David G. Parkers, Paul Mcgonigle
  • Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
    Publication number: 20100125054
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Application
    Filed: December 18, 2009
    Publication date: May 20, 2010
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Andrew A. Young
  • Amylin agonist for treating depression, anxiety disorder and schizophrenia
    Patent number: 7671023
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: March 2, 2010
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Andrew A. Young
  • Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
    Publication number: 20090181890
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Application
    Filed: October 4, 2006
    Publication date: July 16, 2009
    Applicant: Amylin Pharmaceuticals , Inc.
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Andrew A. Young
  • COMPOSITIONS AND METHODS FOR THE CONTROL, PREVENTION AND TREATMENT OF OBESITY AND EATING DISORDERS
    Publication number: 20090062193
    Abstract: Compositions and methods for preventing, treating or controlling conditions or disorders associated with obesity, diet, and nutrition are provided. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to prevent, treat or controlling conditions or disorders associated with obesity, diet, and nutrition.
    Type: Application
    Filed: March 31, 2006
    Publication date: March 5, 2009
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Christian Weyer, Kevin D. Laugero, Christine M. Mack, David G. Parkes
  • Amylin and Amylin Agonists For Treating Psychiatric Diseases and Disorders
    Publication number: 20080287355
    Abstract: Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an amylin or an amylin agonist to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
    Type: Application
    Filed: March 31, 2006
    Publication date: November 20, 2008
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Kevin D. Laugero, Michael R. Hanley, Christine M. Mack, David G. Parkes, Andrew A. Young